As of November 2024, Hinova Pharmaceuticals has a market cap of $372.25M. This makes Hinova Pharmaceuticals the world's 13304th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $489.99M | -32.71% |
2023 | $728.14M | -48.61% |
2022 | $1.42B | -19.36% |
2021 | $1.76B | 41.88% |
2020 | $1.24B | 12.86% |
2019 | $1.10B | 31.44% |
2018 | $834.84M | 24.52% |
2017 | $670.43M | 29.80% |
2016 | $516.52M | -11.68% |
2015 | $584.86M | 11.62% |
2014 | $523.98M | 39.37% |
2013 | $375.96M | -45.11% |
2012 | $684.93M | - |